We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Seaside Therapeutics and Vanderbilt University Enter Collaborative Research Agreement

News   Jan 08, 2010

 
Seaside Therapeutics and Vanderbilt University Enter Collaborative Research Agreement
 
 
Advertisement
 

RELATED ARTICLES

Rapid Test for COVID-19 Shows Improved Sensitivity

News

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard COVID-19 diagnostic.

READ MORE

CRISPR-Based Method Enables Ultrasensitive Visual Detection of SARS-CoV-2

News

In March, UConn researchers began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases such as SARS-CoV-2. Today, the method is one step closer to being a cutting-edge diagnostics technology for rapid detection of infectious diseases.

READ MORE

Chronic vs Episodic Migraine: The Influence of Genetics

News

A research team at KFU looked for genetic markers of migraine in 46 patients with migraine and 50 patients without.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE